Literature DB >> 18158927

Basal cell (trichoblastic) carcinoma common expression pattern for epithelial cell adhesion molecule links basal cell carcinoma to early follicular embryogenesis, secondary hair germ, and outer root sheath of the vellus hair follicle: A clue to the adnexal nature of basal cell carcinoma?

Klaus Sellheyer1, Dieter Krahl.   

Abstract

BACKGROUND: Basal cell carcinoma (BCC) is still viewed by many dermatologists as a tumor of the interfollicular epidermis, although references were made early in the dermatopathologic literature to the resemblance of BCC to the hair follicle.
OBJECTIVE: Our aim was to characterize the common expression pattern for the epithelial cell adhesion molecule (Ep-CAM) in BCCs, various stages of follicular embryogenesis, and adult hair follicles and, thereby, in analogy point to the similarity between BCC and the hair follicle.
METHODS: We studied immunohistochemically 16 superficial BCCs for Ep-CAM and compared the expression pattern with that during hair follicle, nail, and eccrine gland development in human embryos and fetuses. In addition, we examined terminal scalp and vellus hair follicles.
RESULTS: All BCCs expressed Ep-CAM similar to the early stages of the embryonic human hair follicle, the secondary hair germ, and the outer root sheath of the vellus hair follicle. The embryonic nail organ and the adult anagen hair follicles were completely negative. LIMITATIONS: The conclusions are based on the similarity in the immunohistochemical expression profile for a single adhesion molecule.
CONCLUSION: BCC expresses the cell-cell adhesion molecule Ep-CAM similar to the embryonic hair germ, the secondary hair germ of the terminal hair follicle, and the outer root sheath of the vellus hair follicle. We suggest that this may be a clue to the adnexal nature of BCC and propose that BCC is the most primitive follicular tumor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18158927     DOI: 10.1016/j.jaad.2007.07.008

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

Review 1.  Diagnosis and Management of Basal Cell Carcinoma.

Authors:  Keiji Tanese
Journal:  Curr Treat Options Oncol       Date:  2019-02-11

2.  [Malignant nail tumors].

Authors:  E Haneke
Journal:  Hautarzt       Date:  2014-04       Impact factor: 0.751

3.  CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomas.

Authors:  Blanche Ka Ki Lo; Mei Yu; David Zloty; Bryce Cowan; Jerry Shapiro; Kevin John McElwee
Journal:  Am J Pathol       Date:  2010-03-12       Impact factor: 4.307

Review 4.  [Basal cell carcinoma and stem cell markers : Contribution to possible histogenesis?].

Authors:  K Sellheyer
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

Review 5.  Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management.

Authors:  Piyu Parth Naik; Munaf B Desai
Journal:  Oncol Ther       Date:  2022-06-21

6.  Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/beta3-catenin signaling.

Authors:  Steven Hoseong Yang; Thomas Andl; Vladimir Grachtchouk; Aiqin Wang; Jianhong Liu; Li-Jyun Syu; Jenny Ferris; Timothy S Wang; Adam B Glick; Sarah E Millar; Andrzej A Dlugosz
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

Review 7.  Adhesion Molecules in Non-melanoma Skin Cancers: A Comprehensive Review.

Authors:  Joanna Pogorzelska-Dyrbus; Jacek C Szepietowski
Journal:  In Vivo       Date:  2021-04-28       Impact factor: 2.406

8.  Basal Cell Carcinoma on the Sole: An Easily Missed Cancer.

Authors:  Natalie L Hone; Radhika Grandhi; Adam A Ingraffea
Journal:  Case Rep Dermatol       Date:  2016-10-13

9.  A natural WNT signaling variant potently synergizes with Cdkn2ab loss in skin carcinogenesis.

Authors:  Paul Krimpenfort; Margriet Snoek; Jan-Paul Lambooij; Ji-Ying Song; Robin van der Weide; Rajith Bhaskaran; Hans Teunissen; David J Adams; Elzo de Wit; Anton Berns
Journal:  Nat Commun       Date:  2019-03-29       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.